Adjuvant regional isolated perfusion with melphalan for patients with clark V melanoma of the extremities

Keyphrases

• 2-stage 50%
• Absence of Data 50%
• Disease Stage 50%
• EORTC 50%
• Extremity Melanoma 50%
• I(2) 50%
• Isolated Perfusion 100%
• Locoregional Recurrence 50%
• Melanoma 100%
• Melanoma Patients 50%
• Melphalan 100%
• Perfusion 50%
• Primary Tumor 50%
• Prognostic Factors 50%
• Prospective Randomized Trial 50%
• Recurrence Rate 50%
• Regional Lymph Node Metastasis 50%
• Survival Rate 100%
• Wide Local Excision 50%

Medicine and Dentistry

• Disease 25%
• Isolation Perfusion 100%
• Limb 25%
• Lymph Node Metastasis 25%
• Melanoma 100%
• Melphalan 100%
• Primary Tumor 25%
• Recurrence Risk 25%
• Recurrent Disease 25%
• Survival Rate 50%
• Venous Ulcer 25%
• Wide Local Excision 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 25%
• Lymph Node Metastasis 25%
• Melanoma 100%
• Melphalan 100%
• Primary Tumor 25%
• Recurrence Risk 25%
• Recurrent Disease 25%
• Survival Rate 50%
• Ulcer 25%